Group Recreation to Enhance Function Aging

March 13, 2026 updated by: Nikhil Satchidanand, State University of New York at Buffalo

A Community-Based Recreation Program to Improve Function and Quality of Life in Older Adults

Investigators will develop and deliver a community-based recreation program, delivering group artmaking and group SMARTfit dual-task exergaming to community-dwelling older adults. The program will be delivered through the Buffalo-Niagara YMCA. Outcomes of interest are change in cognitive function and change in physical functioning, inresponse to 24 weeks of weekly training.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Nikhil Satchidanand, PhD Exercise Physiology
  • Phone Number: 17168162884
  • Email: ns1@buffalo.edu

Study Locations

  • United States
    • New York
      • Buffalo, New York, United States, 14223
        • Recruiting
        • Buffalo-Niagara YMCA
        • Principal Investigator:
          • Nikhil Satchidanand, PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

  • > = 60 years of age
  • have no more than MCI (MoCA score ≥ 24 points)
  • have no contraindications to exercise, guided by the American College of Sports Medicine
  • fluent in English

Exclusion Criteria

  • have a condition that would prevent safe participation in the exercise, as determined by the Physical Activity Readiness Questionnaire for Older Adults (PAR-OA);
  • have severe neurological disease
  • have severe psychiatric illness
  • have a likelihood of withdrawing from the study due to severe illness or a life expectancy of < 6 mo
  • have experienced a lower or upper limb amputation
  • have greater than mild cognitive impairment (MoCA score < 24 points).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Program
Program participants will receive the recreation-based program.
Behavioral: Exercise and art
Weekly SMARTfit dual-task exergaming and group art-making
No Intervention: Control
Control participants will receive no recreation-based program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive Function: Attention
Time Frame: From enrollment to week 8 and then week 16
Change in performance on the Trail-Making Test
From enrollment to week 8 and then week 16

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance
Time Frame: From enrollment to week 8 and then week 16
Change in balance assessed by the Four Stage Balance Test
From enrollment to week 8 and then week 16
Dual-Task Performance
Time Frame: From enrollment to week 8 and then week 16
Dual task performance assessed using the Timed Up and Go-Dual Task
From enrollment to week 8 and then week 16
Cognitive Function: Interference Inhibition
Time Frame: baseline to week 8, through week 16
Change in performance on the Stroop Test
baseline to week 8, through week 16

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

State University of New York at Buffalo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2025

Primary Completion (Estimated)

July 11, 2026

Study Completion (Estimated)

July 15, 2026

Study Registration Dates

First Submitted

April 8, 2025

First Submitted That Met QC Criteria

June 25, 2025

First Posted (Actual)

July 3, 2025

Study Record Updates

Last Update Posted (Actual)

March 16, 2026

Last Update Submitted That Met QC Criteria

March 13, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 00008757

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Requests to access deidentified participant data can be submitted starting 12 months after article publication and the data will be made accessible for up to 12 months. Access to IPD can be requested by qualified researchers engaging in independent scientific research and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). For more information or to submit a request, contact NS1@buffalo.edu.

IPD Sharing Time Frame

06/15/2026 - 05/14/2027

IPD Sharing Access Criteria

Access to IPD can be requested by qualified researchers engaging in independent scientific research and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Functioning

Clinical Trials on Exercise and art

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe